KR20140038530A - 바이러스 항원 및 백신의 제조 방법 - Google Patents

바이러스 항원 및 백신의 제조 방법 Download PDF

Info

Publication number
KR20140038530A
KR20140038530A KR1020147001348A KR20147001348A KR20140038530A KR 20140038530 A KR20140038530 A KR 20140038530A KR 1020147001348 A KR1020147001348 A KR 1020147001348A KR 20147001348 A KR20147001348 A KR 20147001348A KR 20140038530 A KR20140038530 A KR 20140038530A
Authority
KR
South Korea
Prior art keywords
virus
envelope
viral
chromatography
enveloped
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147001348A
Other languages
English (en)
Korean (ko)
Inventor
이-칭 추이
이딩 왕
조 더스
호프 론 판트
사바 스하케르
로에이 게이르티에 야코바 판
Original Assignee
애보트 바이올로지컬스 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 애보트 바이올로지컬스 비.브이. filed Critical 애보트 바이올로지컬스 비.브이.
Publication of KR20140038530A publication Critical patent/KR20140038530A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020147001348A 2011-07-20 2012-07-04 바이러스 항원 및 백신의 제조 방법 Ceased KR20140038530A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161509630P 2011-07-20 2011-07-20
US61/509,630 2011-07-20
EP11174660.8 2011-07-20
EP11174660 2011-07-20
PCT/EP2012/063045 WO2013010797A1 (en) 2011-07-20 2012-07-04 Process for producing viral antigen and vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020167020663A Division KR20160096215A (ko) 2011-07-20 2012-07-04 바이러스 항원 및 백신의 제조 방법

Publications (1)

Publication Number Publication Date
KR20140038530A true KR20140038530A (ko) 2014-03-28

Family

ID=45094875

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020147001348A Ceased KR20140038530A (ko) 2011-07-20 2012-07-04 바이러스 항원 및 백신의 제조 방법
KR1020167020663A Withdrawn KR20160096215A (ko) 2011-07-20 2012-07-04 바이러스 항원 및 백신의 제조 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020167020663A Withdrawn KR20160096215A (ko) 2011-07-20 2012-07-04 바이러스 항원 및 백신의 제조 방법

Country Status (12)

Country Link
EP (1) EP2734619B1 (enExample)
JP (1) JP6275641B2 (enExample)
KR (2) KR20140038530A (enExample)
CN (1) CN103827296B (enExample)
AU (1) AU2012286098C1 (enExample)
BR (1) BR112014001049A2 (enExample)
CA (1) CA2841604C (enExample)
ES (1) ES2653197T3 (enExample)
MX (1) MX2014000753A (enExample)
RU (1) RU2565827C2 (enExample)
TW (1) TW201311896A (enExample)
WO (1) WO2013010797A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210133732A (ko) * 2020-04-29 2021-11-08 에스케이바이오사이언스(주) 인플루엔자 바이러스 항원 정제 조건 신속 확인 시험

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109568573A (zh) * 2014-12-12 2019-04-05 普莱柯生物工程股份有限公司 疫苗组合物及其制备方法和应用
SG11202004725PA (en) 2017-12-19 2020-07-29 CSL Behring Lengnau AG Protein purification and virus inactivation with alkyl glycosides
JP7360594B2 (ja) * 2017-12-28 2023-10-13 共立製薬株式会社 ワクチン製剤、並びに魚類のイリドウイルス感染症予防方法
US11696948B2 (en) 2018-06-12 2023-07-11 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
US11529413B2 (en) 2018-06-12 2022-12-20 Kbio Holdings Limited Virus and antigen purification and conjugation
KR102714626B1 (ko) 2018-06-12 2024-10-08 케이바이오 홀딩스 리미티드 바이러스 및 항원 정제 및 접합
US11690907B2 (en) 2018-06-12 2023-07-04 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
JP2021528999A (ja) * 2018-07-04 2021-10-28 プロバイオジェン アーゲー エンベロープウイルスの精製方法
JP7518825B2 (ja) 2018-11-15 2024-07-18 バイエル・ヘルスケア・エルエルシー 抗体の連続的製造のためのウイルス不活化方法
RU2710239C1 (ru) * 2019-06-14 2019-12-25 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства Способ получения антигена или антигенов для производства противогриппозной вакцины и вакцина на его основе
EP4054630A2 (en) * 2019-11-07 2022-09-14 Seqirus UK Limited Compositions and methods for producing a viral vaccine with reduced particle size
EP4144753A4 (en) * 2020-04-29 2024-12-25 SK Bioscience Co., Ltd. Influenza virus production method using disposable culture process system, and test for quickly checking conditions for influenza virus antigen purification
CN112309502B (zh) * 2020-10-14 2024-09-20 深圳市新合生物医疗科技有限公司 一种计算肿瘤新抗原负荷的方法及系统
JP2023141423A (ja) * 2022-03-24 2023-10-05 国立大学法人 東京大学 ウイルスの精製方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140762A (en) * 1974-01-14 1979-02-20 Sandoz Ltd. Influenza sub-unit vaccine
US4240762A (en) * 1979-03-12 1980-12-23 Johnston Pump Company Seal-aligning rigid coupling assembly
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
EP1597400B8 (en) * 2003-02-25 2013-10-09 MedImmune, LLC Methods of producing influenza vaccine compositions
RU2283139C1 (ru) * 2005-03-21 2006-09-10 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Способ получения антигенов для вакцины против вирусов гриппа
EP1982727A1 (en) * 2007-04-17 2008-10-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for purification of viral proteins
WO2009029695A1 (en) * 2007-08-28 2009-03-05 Baxter International Inc. Method for producing viral vaccines
US20110014230A1 (en) * 2008-03-18 2011-01-20 Novartis Ag preparation of influenza virus vaccine antigens
AU2009296628B2 (en) * 2008-09-24 2015-01-15 Medimmune, Llc Methods for purification of viruses
US8202726B2 (en) * 2008-09-24 2012-06-19 Medimmune, Llc Methods for cultivating cells, propagating and purifying viruses
GB0918830D0 (en) * 2009-10-27 2009-12-09 Glaxosmithkline Biolog Niederl Process

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210133732A (ko) * 2020-04-29 2021-11-08 에스케이바이오사이언스(주) 인플루엔자 바이러스 항원 정제 조건 신속 확인 시험

Also Published As

Publication number Publication date
AU2012286098C1 (en) 2016-09-15
RU2014101484A (ru) 2015-07-27
EP2734619A1 (en) 2014-05-28
BR112014001049A2 (pt) 2017-02-21
KR20160096215A (ko) 2016-08-12
CA2841604A1 (en) 2013-01-24
EP2734619B1 (en) 2017-09-06
CN103827296B (zh) 2016-11-16
TW201311896A (zh) 2013-03-16
RU2565827C2 (ru) 2015-10-20
AU2012286098A1 (en) 2014-01-23
JP2014524747A (ja) 2014-09-25
WO2013010797A1 (en) 2013-01-24
MX2014000753A (es) 2014-05-07
CA2841604C (en) 2020-01-21
JP6275641B2 (ja) 2018-02-07
CN103827296A (zh) 2014-05-28
ES2653197T3 (es) 2018-02-06

Similar Documents

Publication Publication Date Title
CN103827296B (zh) 用于产生病毒抗原和疫苗的方法
AU2012286098B2 (en) Process for producing viral antigen and vaccines
US11629339B2 (en) Aseptic purification process for viruses
JP6385559B2 (ja) 細胞培養体からのポリオウイルスの精製プロセス
HK1248763A1 (en) Aseptic purification process for viruses
JP2012507272A (ja) 新規な方法
US11999975B2 (en) Method for purifying an enveloped virus
HK1194763A (en) Process for producing viral antigen and vaccines
KR101862332B1 (ko) 인플루엔자 전바이러스 백신 제조 방법
Weigel Development of chromatography-based purification processes for cell culture-derived influenza virus particles
KR20100017593A (ko) 바이러스의 증식을 위한 ２-단계 온도 프로파일
HK1010833B (en) Influenza vaccine
HK1010833A1 (en) Influenza vaccine

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140117

Patent event code: PA01051R01D

Comment text: International Patent Application

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20140224

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150821

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160427

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20150821

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20160727

PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20160427

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20151123

Comment text: Amendment to Specification, etc.

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160825

Patent event code: PE09021S01D

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20161110

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20160825

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20160727

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20160427

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20151123

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20150821